Brainsway Provides $6 Million Milestone-Based Convertible Loan to Neurolief

MT Newswires Live

Mar 26

BrainsWay (BWAY) said Thursday it has completed an additional $6 million milestone-based convertible loan to Neurolief.

The second tranche investment was triggered after the US Food and Drug Administration granted premarket approval for Neurolief's Proliv Rx system, the company said.

BrainsWay said it has invested a total of $11 million in Neurolief to date.

Under the strategic investment agreement, the company may provide additional funding, including a third tranche of up to $5 million in equity upon Neurolief reaching a specified revenue target, it added.

BrainsWay holds a call option to acquire all outstanding equity interests in Neurolief, the company said.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2622051852"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2622051852\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2622051852?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-26 20:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2622051852","market":"us","top_or_hot":-1,"title":"Brainsway Provides $6 Million Milestone-Based Convertible Loan to Neurolief","media":"MT Newswires Live","content":"<html><body><p> BrainsWay (BWAY) said Thursday it has completed an additional $6 million milestone-based convertible loan to Neurolief.</p><p>The second tranche investment was triggered after the US Food and Drug Administration granted premarket approval for Neurolief's Proliv Rx system, the company said.</p><p>BrainsWay said it has invested a total of $11 million in Neurolief to date.</p><p>Under the strategic investment agreement, the company may provide additional funding, including a third tranche of up to $5 million in equity upon Neurolief reaching a specified revenue target, it added.</p><p>BrainsWay holds a call option to acquire all outstanding equity interests in Neurolief, the company said.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Brainsway Provides $6 Million Milestone-Based Convertible Loan to Neurolief</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBrainsway Provides $6 Million Milestone-Based Convertible Loan to Neurolief\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-03-26 20:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> BrainsWay (BWAY) said Thursday it has completed an additional $6 million milestone-based convertible loan to Neurolief.</p><p>The second tranche investment was triggered after the US Food and Drug Administration granted premarket approval for Neurolief's Proliv Rx system, the company said.</p><p>BrainsWay said it has invested a total of $11 million in Neurolief to date.</p><p>Under the strategic investment agreement, the company may provide additional funding, including a third tranche of up to $5 million in equity upon Neurolief reaching a specified revenue target, it added.</p><p>BrainsWay holds a call option to acquire all outstanding equity interests in Neurolief, the company said.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BWAY","symbol_name":"Brainsway Ltd.","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2622051852","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2622051852","pubTimestamp":1774526739,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"BrainsWay  said Thursday it has completed an additional $6 million milestone-based convertible loan to Neurolief.The second tranche investment was triggered after the US Food and Drug Administration granted premarket approval for Neurolief's Proliv Rx system, the company said.BrainsWay said it has invested a total of $11 million in Neurolief to date.Under the strategic investment agreement, the company may provide additional funding, including a third tranche of up to $5 million in equity upon Neurolief reaching a specified revenue target, it added.BrainsWay holds a call option to acquire all outstanding equity interests in Neurolief, the company said.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BWAY":"Brainsway Ltd.","BK4082":"医疗保健设备"},"translate_title":"Brainsway向Neurolief提供600万美元基于里程碑的可转换贷款","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BWAY":1},"content_text":"BrainsWay (BWAY) said Thursday it has completed an additional $6 million milestone-based convertible loan to Neurolief.The second tranche investment was triggered after the US Food and Drug Administration granted premarket approval for Neurolief's Proliv Rx system, the company said.BrainsWay said it has invested a total of $11 million in Neurolief to date.Under the strategic investment agreement, the company may provide additional funding, including a third tranche of up to $5 million in equity upon Neurolief reaching a specified revenue target, it added.BrainsWay holds a call option to acquire all outstanding equity interests in Neurolief, the company said.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}